Alpha Tau Medical (DRTS) vs SpyGlass Pharma (SGP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Alpha Tau Medical is the larger company by market cap ($1.09 billion vs $1.02 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DRTS | SGP |
|---|---|---|
| Share price | $11.76 | $30.43 |
| Market cap | $1.09B | $1.02B |
| 1-day change | +3.93% | -1.14% |
| YTD return | +137.47% | — |
| 1-year return | +207.72% | — |
| 5-year return | +18.50% | — |
| EPS (TTM) | $-1.04 | $-2.70 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-42.63M | $-39.87M |
| 52-week high | $15.79 | $39.92 |
| 52-week low | $3.65 | $17.06 |
| Distance from 52-week high | -25.55% | -23.77% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +75.24% | +53.37% |
| Average volume | 591.88K | 114.63K |
| Shares outstanding | 92.48M | 33.46M |
| Employees | 121 | 88 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Alpha Tau Medical
DRTS stock →Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.
Health Care · Medical/Dental Instruments · 121 employees
About SpyGlass Pharma
SGP stock →SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions.
Health Care · Medical/Dental Instruments · 88 employees
DRTS vs SGP FAQ
Which is bigger, Alpha Tau Medical or SpyGlass Pharma?
Alpha Tau Medical (DRTS) is larger, with a market capitalization of $1.09B compared with $1.02B for SpyGlass Pharma (SGP).
Are Alpha Tau Medical and SpyGlass Pharma in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.